1. Home
  2. XYLO vs CPHI Comparison

XYLO vs CPHI Comparison

Compare XYLO & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • CPHI
  • Stock Information
  • Founded
  • XYLO 1999
  • CPHI N/A
  • Country
  • XYLO Israel
  • CPHI China
  • Employees
  • XYLO N/A
  • CPHI N/A
  • Industry
  • XYLO
  • CPHI Biotechnology: Pharmaceutical Preparations
  • Sector
  • XYLO
  • CPHI Health Care
  • Exchange
  • XYLO NYSE
  • CPHI Nasdaq
  • Market Cap
  • XYLO 6.1M
  • CPHI 7.3M
  • IPO Year
  • XYLO N/A
  • CPHI N/A
  • Fundamental
  • Price
  • XYLO $5.18
  • CPHI $1.83
  • Analyst Decision
  • XYLO
  • CPHI
  • Analyst Count
  • XYLO 0
  • CPHI 0
  • Target Price
  • XYLO N/A
  • CPHI N/A
  • AVG Volume (30 Days)
  • XYLO 3.0K
  • CPHI 152.1K
  • Earning Date
  • XYLO 07-07-2025
  • CPHI 08-13-2025
  • Dividend Yield
  • XYLO N/A
  • CPHI N/A
  • EPS Growth
  • XYLO N/A
  • CPHI N/A
  • EPS
  • XYLO N/A
  • CPHI N/A
  • Revenue
  • XYLO $29,858,000.00
  • CPHI $4,295,377.00
  • Revenue This Year
  • XYLO $279.19
  • CPHI N/A
  • Revenue Next Year
  • XYLO N/A
  • CPHI N/A
  • P/E Ratio
  • XYLO N/A
  • CPHI N/A
  • Revenue Growth
  • XYLO N/A
  • CPHI N/A
  • 52 Week Low
  • XYLO $2.70
  • CPHI $1.20
  • 52 Week High
  • XYLO $6.67
  • CPHI $3.35
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 54.95
  • CPHI 52.11
  • Support Level
  • XYLO $4.85
  • CPHI $1.55
  • Resistance Level
  • XYLO $5.18
  • CPHI $1.91
  • Average True Range (ATR)
  • XYLO 0.20
  • CPHI 0.18
  • MACD
  • XYLO 0.02
  • CPHI 0.02
  • Stochastic Oscillator
  • XYLO 92.00
  • CPHI 61.38

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in four segments are: Corporate, Online advertising & internet traffic routing, Online event management, real-estate and electronics. The company's geographical segments include USA, Europe, Great Britain, Israel, Canada, Asia and others.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: